会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Cyclic urethanes useful as antiarrhythmic and antifibrillatory agents
    • 循环尿烷可用作抗心律失常药和抗纤维化剂
    • US5994354A
    • 1999-11-30
    • US479254
    • 1995-06-07
    • Stanford Salvatore Pelosi, Jr.Chia-Nien Yu
    • Stanford Salvatore Pelosi, Jr.Chia-Nien Yu
    • A61K31/42A61K31/34A61K31/41A61K31/422A61K31/495A61P9/06C07D263/14C07D413/12C07D413/14A61K31/445
    • C07D413/10C07D413/12C07D413/14
    • The novel cyclic urethanes, and their pharmaceutically-acceptable salts and esters, described herein which are useful as antiarrhythmic and antifibrillatory agents and have the following general structure: ##STR1## wherein (a) X is a saturated or unsaturated, 5-, 6-, or 7-membered heterocycle or carbocycle;(b) Y is a substituted or unsubstituted, saturated or unsaturated, 5-, 6-, or 7-membered heterocyclic ring or carbocyclic ring, or is nil;(c) L is selected from the group consisting of alkylamino, alkenylamino, alkylimino, alkenylimino and acylamino; wherein the nitrogen atom thereof is bound to the nitrogen atom at the 3-position of the cyclic urethane ring moiety;(d) A is a substituted or unsubstituted, saturated or unsaturated, straight-chain or branched, C.sub.1 -C.sub.8 heteroalkyl; or a substituted or unsubstituted, saturated or unsaturated heterocycle having 6- or 7-members which may not have an oxygen atom; and A has one nitrogen atom which is adjacent to R.sub.4 ; andand the pharmaceutically-acceptable salts and esters thereof.
    • 本文所述的新型环状聚氨酯及其药学上可接受的盐和酯,其可用作抗心律失常和抗纤颤剂,并具有以下通用结构:其中(a)X为饱和或不饱和的5-,6-或7 杂环或碳环; (b)Y是取代或未取代的饱和或不饱和的5-,6-或7-元杂环或碳环,或不为零; (c)L选自烷基氨基,烯基氨基,烷基亚氨基,烯基亚氨基和酰基氨基; 其中氮原子与环状氨基甲酸酯环部分的3-位的氮原子结合; (d)A是取代或未取代的饱和或不饱和的直链或支链C 1 -C 8杂烷基; 或具有6或7个不具有氧原子的取代或未取代的饱和或不饱和杂环; 并且A具有与R 4相邻的一个氮原子; 及其药学上可接受的盐和酯。